Cargando…

Structural and Electrophysiological Changes in a Model of Cardiotoxicity Induced by Anthracycline Combined With Trastuzumab

BACKGROUND: Combined treatment with anthracyclines (e.g., doxorubicin; Dox) and trastuzumab (Trz), a humanized anti-human epidermal growth factor receptor 2 (HER2; ErbB2) antibody, in patients with HER2-positive cancer is limited by cardiotoxicity, as manifested by contractile dysfunction and arrhyt...

Descripción completa

Detalles Bibliográficos
Autores principales: Altomare, Claudia, Lodrini, Alessandra Maria, Milano, Giuseppina, Biemmi, Vanessa, Lazzarini, Edoardo, Bolis, Sara, Pernigoni, Nicolò, Torre, Eleonora, Arici, Martina, Ferrandi, Mara, Barile, Lucio, Rocchetti, Marcella, Vassalli, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8058443/
https://www.ncbi.nlm.nih.gov/pubmed/33897465
http://dx.doi.org/10.3389/fphys.2021.658790
_version_ 1783681015982587904
author Altomare, Claudia
Lodrini, Alessandra Maria
Milano, Giuseppina
Biemmi, Vanessa
Lazzarini, Edoardo
Bolis, Sara
Pernigoni, Nicolò
Torre, Eleonora
Arici, Martina
Ferrandi, Mara
Barile, Lucio
Rocchetti, Marcella
Vassalli, Giuseppe
author_facet Altomare, Claudia
Lodrini, Alessandra Maria
Milano, Giuseppina
Biemmi, Vanessa
Lazzarini, Edoardo
Bolis, Sara
Pernigoni, Nicolò
Torre, Eleonora
Arici, Martina
Ferrandi, Mara
Barile, Lucio
Rocchetti, Marcella
Vassalli, Giuseppe
author_sort Altomare, Claudia
collection PubMed
description BACKGROUND: Combined treatment with anthracyclines (e.g., doxorubicin; Dox) and trastuzumab (Trz), a humanized anti-human epidermal growth factor receptor 2 (HER2; ErbB2) antibody, in patients with HER2-positive cancer is limited by cardiotoxicity, as manifested by contractile dysfunction and arrhythmia. The respective roles of the two agents in the cardiotoxicity of the combined therapy are incompletely understood. OBJECTIVE: To assess cardiac performance, T-tubule organization, electrophysiological changes and intracellular Ca(2+) handling in cardiac myocytes (CMs) using an in vivo rat model of Dox/Trz-related cardiotoxicity. METHODS AND RESULTS: Adult rats received 6 doses of either Dox or Trz, or the two agents sequentially. Dox-mediated left ventricular (LV) dysfunction was aggravated by Trz administration. Dox treatment, but not Trz, induced T-tubule disarray. Moreover, Dox, but not Trz monotherapy, induced prolonged action potential duration (APD), increased incidence of delayed afterdepolarizations (DADs) and beat-to-beat variability of repolarization (BVR), and slower Ca(2+) transient decay. Although APD, DADs, BVR and Ca(2+) transient decay recovered over time after the cessation of Dox treatment, subsequent Trz administration exacerbated these abnormalities. Trz, but not Dox, reduced Ca(2+) transient amplitude and SR Ca(2+) content, although only Dox treatment was associated with SERCA downregulation. Finally, Dox treatment increased Ca(2+) spark frequency, resting Ca(2+) waves, sarcoplasmic reticulum (SR) Ca(2+) leak, and long-lasting Ca(2+) release events (so-called Ca(2+) “embers”), partially reproduced by Trz treatment. CONCLUSION: These results suggest that in vivo Dox but not Trz administration causes T-tubule disarray and pronounced changes in electrical activity of CMs. While adaptive changes may account for normal AP shape and reduced DADs late after Dox administration, subsequent Trz administration interferes with such adaptive changes. Intracellular Ca(2+) handling was differently affected by Dox and Trz treatment, leading to SR instability in both cases. These findings illustrate the specific roles of Dox and Trz, and their interactions in cardiotoxicity and arrhythmogenicity.
format Online
Article
Text
id pubmed-8058443
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-80584432021-04-22 Structural and Electrophysiological Changes in a Model of Cardiotoxicity Induced by Anthracycline Combined With Trastuzumab Altomare, Claudia Lodrini, Alessandra Maria Milano, Giuseppina Biemmi, Vanessa Lazzarini, Edoardo Bolis, Sara Pernigoni, Nicolò Torre, Eleonora Arici, Martina Ferrandi, Mara Barile, Lucio Rocchetti, Marcella Vassalli, Giuseppe Front Physiol Physiology BACKGROUND: Combined treatment with anthracyclines (e.g., doxorubicin; Dox) and trastuzumab (Trz), a humanized anti-human epidermal growth factor receptor 2 (HER2; ErbB2) antibody, in patients with HER2-positive cancer is limited by cardiotoxicity, as manifested by contractile dysfunction and arrhythmia. The respective roles of the two agents in the cardiotoxicity of the combined therapy are incompletely understood. OBJECTIVE: To assess cardiac performance, T-tubule organization, electrophysiological changes and intracellular Ca(2+) handling in cardiac myocytes (CMs) using an in vivo rat model of Dox/Trz-related cardiotoxicity. METHODS AND RESULTS: Adult rats received 6 doses of either Dox or Trz, or the two agents sequentially. Dox-mediated left ventricular (LV) dysfunction was aggravated by Trz administration. Dox treatment, but not Trz, induced T-tubule disarray. Moreover, Dox, but not Trz monotherapy, induced prolonged action potential duration (APD), increased incidence of delayed afterdepolarizations (DADs) and beat-to-beat variability of repolarization (BVR), and slower Ca(2+) transient decay. Although APD, DADs, BVR and Ca(2+) transient decay recovered over time after the cessation of Dox treatment, subsequent Trz administration exacerbated these abnormalities. Trz, but not Dox, reduced Ca(2+) transient amplitude and SR Ca(2+) content, although only Dox treatment was associated with SERCA downregulation. Finally, Dox treatment increased Ca(2+) spark frequency, resting Ca(2+) waves, sarcoplasmic reticulum (SR) Ca(2+) leak, and long-lasting Ca(2+) release events (so-called Ca(2+) “embers”), partially reproduced by Trz treatment. CONCLUSION: These results suggest that in vivo Dox but not Trz administration causes T-tubule disarray and pronounced changes in electrical activity of CMs. While adaptive changes may account for normal AP shape and reduced DADs late after Dox administration, subsequent Trz administration interferes with such adaptive changes. Intracellular Ca(2+) handling was differently affected by Dox and Trz treatment, leading to SR instability in both cases. These findings illustrate the specific roles of Dox and Trz, and their interactions in cardiotoxicity and arrhythmogenicity. Frontiers Media S.A. 2021-04-07 /pmc/articles/PMC8058443/ /pubmed/33897465 http://dx.doi.org/10.3389/fphys.2021.658790 Text en Copyright © 2021 Altomare, Lodrini, Milano, Biemmi, Lazzarini, Bolis, Pernigoni, Torre, Arici, Ferrandi, Barile, Rocchetti and Vassalli. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Physiology
Altomare, Claudia
Lodrini, Alessandra Maria
Milano, Giuseppina
Biemmi, Vanessa
Lazzarini, Edoardo
Bolis, Sara
Pernigoni, Nicolò
Torre, Eleonora
Arici, Martina
Ferrandi, Mara
Barile, Lucio
Rocchetti, Marcella
Vassalli, Giuseppe
Structural and Electrophysiological Changes in a Model of Cardiotoxicity Induced by Anthracycline Combined With Trastuzumab
title Structural and Electrophysiological Changes in a Model of Cardiotoxicity Induced by Anthracycline Combined With Trastuzumab
title_full Structural and Electrophysiological Changes in a Model of Cardiotoxicity Induced by Anthracycline Combined With Trastuzumab
title_fullStr Structural and Electrophysiological Changes in a Model of Cardiotoxicity Induced by Anthracycline Combined With Trastuzumab
title_full_unstemmed Structural and Electrophysiological Changes in a Model of Cardiotoxicity Induced by Anthracycline Combined With Trastuzumab
title_short Structural and Electrophysiological Changes in a Model of Cardiotoxicity Induced by Anthracycline Combined With Trastuzumab
title_sort structural and electrophysiological changes in a model of cardiotoxicity induced by anthracycline combined with trastuzumab
topic Physiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8058443/
https://www.ncbi.nlm.nih.gov/pubmed/33897465
http://dx.doi.org/10.3389/fphys.2021.658790
work_keys_str_mv AT altomareclaudia structuralandelectrophysiologicalchangesinamodelofcardiotoxicityinducedbyanthracyclinecombinedwithtrastuzumab
AT lodrinialessandramaria structuralandelectrophysiologicalchangesinamodelofcardiotoxicityinducedbyanthracyclinecombinedwithtrastuzumab
AT milanogiuseppina structuralandelectrophysiologicalchangesinamodelofcardiotoxicityinducedbyanthracyclinecombinedwithtrastuzumab
AT biemmivanessa structuralandelectrophysiologicalchangesinamodelofcardiotoxicityinducedbyanthracyclinecombinedwithtrastuzumab
AT lazzariniedoardo structuralandelectrophysiologicalchangesinamodelofcardiotoxicityinducedbyanthracyclinecombinedwithtrastuzumab
AT bolissara structuralandelectrophysiologicalchangesinamodelofcardiotoxicityinducedbyanthracyclinecombinedwithtrastuzumab
AT pernigoninicolo structuralandelectrophysiologicalchangesinamodelofcardiotoxicityinducedbyanthracyclinecombinedwithtrastuzumab
AT torreeleonora structuralandelectrophysiologicalchangesinamodelofcardiotoxicityinducedbyanthracyclinecombinedwithtrastuzumab
AT aricimartina structuralandelectrophysiologicalchangesinamodelofcardiotoxicityinducedbyanthracyclinecombinedwithtrastuzumab
AT ferrandimara structuralandelectrophysiologicalchangesinamodelofcardiotoxicityinducedbyanthracyclinecombinedwithtrastuzumab
AT barilelucio structuralandelectrophysiologicalchangesinamodelofcardiotoxicityinducedbyanthracyclinecombinedwithtrastuzumab
AT rocchettimarcella structuralandelectrophysiologicalchangesinamodelofcardiotoxicityinducedbyanthracyclinecombinedwithtrastuzumab
AT vassalligiuseppe structuralandelectrophysiologicalchangesinamodelofcardiotoxicityinducedbyanthracyclinecombinedwithtrastuzumab